Clinical trial: Esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2010, Pages 182-190

  Johnson, D ^a   Crawley, J A ^b   Hwang, C ^b   Brown, K ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; NIGHT SLEEP; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; VOMITING; WORK CAPACITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SLEEP DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953775776     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04339.x     Document Type: Article

References (25)

1. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001 161 : 45 52.
2. Shaker R, Castell DO, Schoenfeld PS, et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup Survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003 98 : 1487 1493.
3. Dubois RW, Aguilar D, Fass R, et al. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther 2007 25 : 487 500.
4. Mody R, Bolge SC, Kannan H, et al. Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol 2009 7 : 953 959.
5. Janson C, Gislason T, De Backer W, et al. Prevalence of sleep disturbances among young adults in three European countries. Sleep 1995 18 : 589 597.
6. Wahlqvist P, Carlsson J, Stålhammar N-O, et al. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD) - results from a cross-sectional study. Value Health 2002 5 : 106 113.
7. Dean BB, Crawley JA, Reeves JD, et al. The cost of gastroesophageal reflux disease: it's what you don't see that counts. J Manag Care Med 2003 7 : 6 13.
8. Newman AB, Spiekerman CF, Enright P, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000 48 : 115 123.
9. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 831.
10. Jaspersen D. Extra-esophageal disorders in gastroesophageal reflux disease. Dig Dis 2004 22 : 115 119. (Pubitemid 39274306)
11. Orr WC, Heading R, Johnson LF, et al. Review article: sleep and its relationship to gastro-oesophageal reflux. Aliment Pharmacol Ther 2004 20 (Suppl 9 39 46.
12. Chen C-L, Robert JJT, Orr WC. Sleep symptoms and gastroesophageal reflux. J Clin Gastroenterol 2008 42 : 13 7.
13. Wahlqvist P, Karlsson M, Johnson D, et al. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther 2008 27 : 960 970.
14. Johnson DA, Orr WC, Crawley JA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol 2005 100 : 1914 1922.
15. Orr WC, Goodrich S, Robert J. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther 2005 21 : 103 108.
16. Chand N, Johnson DA, Tabangin M, et al. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study. Aliment Pharmacol Ther 2004 20 : 969 974.
17. DiMarino AJ Jr., Banwait KS, Eschinger E, et al. The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters. Aliment Pharmacol Ther 2005 22 : 325 329.
18. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003 18 : 767 776.
19. Yi CH, Chen CL, Kuo TB, et al. The effect of acid suppression on sleep and cardiac autonomic regulation in GERD. Hepatogastroenterology 2008 55 : 1649 1652.
20. AstraZeneca LP. Nexium [prescribing information].
21. Buysse DJ, Reynolds CF III., Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989 28 : 193 213.
22. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993 4 : 353 365.
23. Bureau of Labor Statistics. Employer costs for employee compensation news release. Available at: http://www.bls.gov/news.release/ecec.htm. Accessed June 2008.
24. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997 112 : 1798 1810.
25. Peura DA, Riff DS, Snoddy AM, et al. Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. Aliment Pharmacol Ther 2009 30 : 459 468.